Defiance Daily Target 2X Long NVO ETF (NVOX)

Assets	$38.14M
Expense Ratio	1.31%
PE Ratio	n/a
Shares Out	3.88M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	481,216
Open	9.16
Previous Close	9.15
Day's Range	9.04 - 9.25
52-Week Low	9.04
52-Week High	33.84
Beta	n/a
Holdings	12
Inception Date	Dec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSE Arca
• Ticker Symbol: NVOX
• ETF Provider: Defiance

Top 10 Holdings

305.44% of assets

Name	Symbol	Weight
United States Treasury Bills 0%	B.0 11.19.26	64.42%
NOVO-NORDISK SWAP MS	n/a	48.70%
NOVO-NORDISK SWAP CLEARSTREET	n/a	29.35%
NOVO-NORDISK SWAP MAREX	n/a	28.97%
NOVO-NORDISK INC SWAP CANTOR	n/a	28.68%
NOVO-NORDISK A/S-SPONS ADR NOMURA	n/a	26.47%
NOVO-NORDISK SWAP NBC-L	n/a	25.55%
OTHER ASSETS AND LIABILITIES	n/a	21.01%
US DOLLARS	n/a	17.22%
NOVO-NORDISK SWAP BMO-L	n/a	15.06%

Performance

NVOX had a total return of -71.56% in the past year, including dividends. Since the fund's inception, the average annual return has been -79.59%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 3, 2026

Data Sources Report a data error